# Serum-Ascites Albumin Gradient Analysis in Cancer Patients in Palliative Care

> **NCT03463655** · — · UNKNOWN · sponsor: **Institut Paoli-Calmettes** · enrollment: 50 (estimated)

## Conditions studied

- Solid Cancer in a Palliative Situation With Ascites

## Interventions

- **DIAGNOSTIC_TEST:** cirrhotic albumin
- **DIAGNOSTIC_TEST:** serum albumin

## Key facts

- **NCT ID:** NCT03463655
- **Lead sponsor:** Institut Paoli-Calmettes
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-12-21
- **Primary completion:** 2018-03
- **Final completion:** 2018-04
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2018-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03463655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03463655, "Serum-Ascites Albumin Gradient Analysis in Cancer Patients in Palliative Care". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03463655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*